Biocon Biologics and Viatris launch first-ever interchangeable biosimilars SEMGLEE and Insulin Glargine injection in US, Health News, ET HealthWorld
Bengaluru : Biocon Biologics Ltd, a subsidiary of Biocon and Viatris Inc, announced the US launch of interchangeable biosimilars SEMGLEE ...
